Researchers Debate Costs Of Clinical Trial Data Sharing At IOM Gathering
This article was originally published in The Gray Sheet
The costs associated with more expansive sharing of clinical trial data for independent research would be significant, experts warned at a meeting convened by the Institute of Medicine to help inform a planned study on strategies for increasing trial data-sharing.
You may also be interested in...
Johnson & Johnson's device and diagnostic clinical trial data is now available to independent researchers via Yale University’s Open Data Access (YODA) Project, announced the same day as an Institute of Medicine report mapping out strategies for clinical trial data-sharing.
Independent researchers will be able to request access to clinical trial data for any J&J drug from clinicians at Yale’s Open Data Access Project without involvement by the company. J&J is now in discussions to set up a similar arrangement for its device and consumer products trial data.
The Institute of Medicine issued a draft framework for a study on expanding clinical trial data sharing and is seeking input from outside parties. The draft discusses how competing firms, disease advocacy groups and the media might responsibly use data shared by clinical trial sponsors.